Betterlife Pharma Inc (BETR.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 01/31
| 04-2024 | 01-2024 | 10-2023 | 07-2023 | 04-2023 | |
| Cash Flows From Operating Activities | |||||
| Accounts receivable | 17 | -27 | -1 | 24 | -19 |
| Accounts payable and accrued liabilities | -423 | -83 | 63 | 63 | -745 |
| Other Working Capital | -484 | 483 | 197 | 322 | -680 |
| Other Operating Activity | 31 | -628 | -656 | -875 | 89 |
| Operating Cash Flow | $-859 | $-255 | $-396 | $-466 | $-1,355 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,224 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 0 | 100 | 287 | 220 | 1,594 |
| Other Financing Activity | 20 | 100 | 140 | 60 | 0 |
| Financing Cash Flow | $1,244 | $200 | $427 | $280 | $1,594 |
| Beginning Cash Position | 37 | 93 | 61 | 247 | 8 |
| End Cash Position | 423 | 37 | 93 | 61 | 247 |
| Net Cash Flow | $385 | $-55 | $32 | $-186 | $239 |
| Free Cash Flow | |||||
| Operating Cash Flow | -859 | -255 | -396 | -466 | -1,355 |
| Free Cash Flow | -859 | -255 | -396 | -466 | -1,355 |